Literature DB >> 20029234

Growth in Noonan syndrome.

B J Otten1, C Noordam.   

Abstract

Growth failure in Noonan syndrome is mainly postnatal of character and is dominated by slow maturation and late puberty. The postnatal early decline seems to be an intrinsic part of the syndrome. Reported adult heights are about -2 SD and are indicative of a secular trend. 2009 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20029234     DOI： 10.1159/000243776

Source DB:  PubMed          Journal:  Horm Res        ISSN： 0301-0163


  11 in total

1.  Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry.

Authors:  Peter A Lee; Judith Ross; John A Germak; Robert Gut
Journal:  Int J Pediatr Endocrinol       Date:  2012-06-08

2.  Growth references for Japanese individuals with Noonan syndrome.

Authors:  Tsuyoshi Isojima; Satoru Sakazume; Tomonobu Hasegawa; Tsutomu Ogata; Toshio Nakanishi; Toshiro Nagai; Susumu Yokoya
Journal:  Pediatr Res       Date:  2015-12-09       Impact factor: 3.953

3.  Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program.

Authors:  Peter A Lee; Judith L Ross; Birgitte Tønnes Pedersen; Primoz Kotnik; John A Germak; Henrik T Christesen
Journal:  Int J Pediatr Endocrinol       Date:  2015-09-08

Review 4.  Syndromic disorders with short stature.

Authors:  Zeynep Şıklar; Merih Berberoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014

5.  Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome.

Authors:  Insook Jeong; Eungu Kang; Ja Hyang Cho; Gu-Hwan Kim; Beom Hee Lee; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31

Review 6.  Development of disease-specific growth charts in Turner syndrome and Noonan syndrome.

Authors:  Tsuyoshi Isojima; Susumu Yokoya
Journal:  Ann Pediatr Endocrinol Metab       Date:  2017-12-31

7.  Pathogenic gene screening in 91 Chinese patients with short stature of unknown etiology with a targeted next-generation sequencing panel.

Authors:  Lulu Yang; Chenhui Zhang; Wei Wang; Junqi Wang; Yuan Xiao; Wenli Lu; Xiaoyu Ma; Lifen Chen; Jihong Ni; Defen Wang; Jinxiu Shi; Zhiya Dong
Journal:  BMC Med Genet       Date:  2018-12-12       Impact factor: 2.103

8.  Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.

Authors:  Jeevana Praharsha Athota; Meenakshi Bhat; Sheela Nampoothiri; Kalpana Gowrishankar; Sanjeeva Ghanti Narayanachar; Vinuth Puttamallesh; Mohammed Oomer Farooque; Swathi Shetty
Journal:  BMC Med Genet       Date:  2020-03-12       Impact factor: 2.103

9.  Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height.

Authors:  Annachiara Libraro; Vito D'Ascanio; Marco Cappa; Mariangela Chiarito; Maria Cristina Digilio; Silvia Einaudi; Anna Grandone; Mohamad Maghnie; Laura Mazzanti; Alessandro Mussa; Giuseppa Patti; Emanuela Scarano; Antonietta Spinuzza; Silvia Vannelli; Malgorzata Gabriela Wasniewska; Giovanni Battista Ferrero; Maria Felicia Faienza
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-22       Impact factor: 5.555

10.  Variations in Multiple Syndromic Deafness Genes Mimic Non-syndromic Hearing Loss.

Authors:  G Bademci; F B Cengiz; J Foster Ii; D Duman; L Sennaroglu; O Diaz-Horta; T Atik; T Kirazli; L Olgun; H Alper; I Menendez; I Loclar; G Sennaroglu; S Tokgoz-Yilmaz; S Guo; Y Olgun; N Mahdieh; M Bonyadi; N Bozan; A Ayral; F Ozkinay; M Yildirim-Baylan; S H Blanton; M Tekin
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.